Page last updated: 2024-10-25

clomipramine and Body Weight

clomipramine has been researched along with Body Weight in 23 studies

Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"This double-blind controlled study examines the impact of clomipramine when taken by an anorexia nervosa population, refeeding in hospital, over and above that generated by the established treatment programme."9.05Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. ( Crisp, AH; Lacey, JH, 1980)
"Long-term treatment with clomipramine (CMI), a tricyclic antidepressant, induces food craving and body weight gain in patients."7.74Effect of chronic treatment with clomipramine on food intake, macronutrient selection and body weight gain in rats. ( Calegari, L; Gentil, V; Gorenstein, C; Nunes-de-Souza, RL; Planeta, CS, 2007)
" In this study we have examined the impact of clomipramine on food and activity in anorectics engaged in a treatment programme enabling them to regain normal body weight."7.67Clomipramine and 'drive' in people with anorexia nervosa: an in-patient study. ( Crisp, AH; Crutchfield, M; Lacey, JH, 1987)
" Three tricyclic antidepressants examined (imipramine, clomipramine and desipramine) did not seem to have the side effect of pathological weight gain in the frequency distribution pattern."5.07Changes in the frequency distribution pattern of body weight in patients with major depression. ( Kato, T; Murashita, J; Shioiri, T; Takahashi, S; Yamada, N, 1993)
"This double-blind controlled study examines the impact of clomipramine when taken by an anorexia nervosa population, refeeding in hospital, over and above that generated by the established treatment programme."5.05Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population. ( Crisp, AH; Lacey, JH, 1980)
" During and at the end point of the chronic stress experiment, food consumption, body weight, adrenal gland, thymus and spleen indices, behavior scores, sucrose consumption, and stress hormone levels were measured."3.78Metabonomics approach to assessing the modulatory effects of St John's wort, ginsenosides, and clomipramine in experimental depression. ( Chen, T; Jia, W; Jia, Z; Jiang, T; Lin, J; Qiu, Y; Su, M; Wang, X; Xie, X; Zeng, C; Zhao, A; Zhao, T; Zhou, M, 2012)
" Caffeine in a dose of 100 mg/kg body weight enhanced the recovery of the prednisolone-suppressed HPA axis significantly."3.68Caffeine enhances the speed of the recovery of the hypothalamo-pituitary-adrenocortical axis after chronic prednisolone administration in the rat. ( Abou-Hashim, EM; Blijd, JJ; de Jong, FH; el-Kannishy, MH; Lamberts, SW; Marzouk, HF; Uitterlinden, P; van Koetsveld, P; Zuyderwijk, J, 1991)
" CMI significantly reduced food intake and body weight gain, but did not alter either adrenal weight or basal serum corticosterone levels."3.67Previous chronic chlorimipramine treatment did not modify some physiological responses to acute and chronic stress in rats. ( Armario, A; García-Marquez, C; Giralt, M, 1988)
" In this study we have examined the impact of clomipramine on food and activity in anorectics engaged in a treatment programme enabling them to regain normal body weight."3.67Clomipramine and 'drive' in people with anorexia nervosa: an in-patient study. ( Crisp, AH; Crutchfield, M; Lacey, JH, 1987)
"Mianserin (60 mg daily) was compared with chlorimipramine (150 mg daily) in the treatment of 145 depressed in- and outpatients in four centres."2.65A double-blind multicentre trial comparing the efficacy and side-effects of mianserin and chlorimipramine in depressed in- and outpatients. ( Barres, M; Blum, A; Charbaut, J; Israel, L; Kammerer, T; Molczadzki, M; Pinder, RM; Rigaud, A; Stulemeijer, SM, 1980)
"Clomipramine-treated animals had shifts in the laterality of monoamines in limbic regions with lower serotonin levels on the right side while vehicle-treated animals had lower serotonin on the left side."1.31Differences in behavior and monoamine laterality following neonatal clomipramine treatment. ( Andersen, SL; Dumont, NL; Teicher, MH, 2002)
"Patients treated with four dosage regimes of clomipramine (Anafranil) 10 mg t."1.26An investigation into the short-term effects of clomipramine (Anafranil) administered in low doses, on weight. ( Beaumont, G, 1977)

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-199015 (65.22)18.7374
1990's2 (8.70)18.2507
2000's4 (17.39)29.6817
2010's2 (8.70)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qin, D1
Chu, X1
Feng, X1
Li, Z1
Yang, S1
Lü, L1
Yang, Q1
Pan, L1
Yin, Y1
Li, J1
Xu, L1
Chen, L1
Hu, X1
Wang, X1
Zeng, C1
Lin, J1
Chen, T1
Zhao, T1
Jia, Z1
Xie, X1
Qiu, Y1
Su, M1
Jiang, T1
Zhou, M1
Zhao, A1
Jia, W1
Andersen, SL1
Dumont, NL1
Teicher, MH1
van der Hart, MG1
Czéh, B1
de Biurrun, G1
Michaelis, T1
Watanabe, T1
Natt, O1
Frahm, J1
Fuchs, E1
Maciag, D1
Simpson, KL1
Coppinger, D1
Lu, Y1
Wang, Y1
Lin, RC1
Paul, IA1
Calegari, L1
Gorenstein, C1
Gentil, V1
Planeta, CS1
Nunes-de-Souza, RL1
Verberne, AJ1
Taylor, DA1
Fennessy, MR1
Agras, WS1
Kraemer, HC1
File, SE1
Tucker, JC1
Lacey, JH2
Crisp, AH2
Pinder, RM1
Blum, A1
Stulemeijer, SM1
Barres, M1
Molczadzki, M1
Rigaud, A1
Charbaut, J1
Israel, L1
Kammerer, T1
Mirmiran, M2
van de Poll, NE2
Corner, MA2
van Oyen, HG2
Bour, HL2
Boer, GJ1
Uylings, HB1
Shioiri, T1
Kato, T1
Murashita, J1
Yamada, N1
Takahashi, S1
Laguzzi, RF1
Adrien, J1
Bourgoin, S1
Hamon, M1
Broitman, ST1
Donoso, AO1
Broadhurst, AD1
James, HD1
Corte, LD1
Heeley, AF1
Groom, GV1
Evans, G1
Beaumont, G1
O'Flanagan, PM1
Marzouk, HF1
Zuyderwijk, J1
Uitterlinden, P1
van Koetsveld, P1
Blijd, JJ1
Abou-Hashim, EM1
el-Kannishy, MH1
de Jong, FH1
Lamberts, SW1
Armario, A1
García-Marquez, C1
Giralt, M1
Crutchfield, M1

Trials

4 trials available for clomipramine and Body Weight

ArticleYear
The treatment of anorexia nervosa: do different treatments have different outcomes?
    Research publications - Association for Research in Nervous and Mental Disease, 1984, Volume: 62

    Topics: Adolescent; Amitriptyline; Anorexia Nervosa; Behavior Therapy; Body Weight; Clinical Trials as Topic

1984
Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population.
    Postgraduate medical journal, 1980, Volume: 56 Suppl 1

    Topics: Anorexia Nervosa; Body Weight; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Eating;

1980
A double-blind multicentre trial comparing the efficacy and side-effects of mianserin and chlorimipramine in depressed in- and outpatients.
    International pharmacopsychiatry, 1980, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Body Weight; Clinical Trials as Topic; Clomipramine; Depressive Disorder; D

1980
Changes in the frequency distribution pattern of body weight in patients with major depression.
    Acta psychiatrica Scandinavica, 1993, Volume: 88, Issue:5

    Topics: Adult; Antidepressive Agents, Tricyclic; Body Weight; Clomipramine; Depressive Disorder; Desipramine

1993

Other Studies

19 other studies available for clomipramine and Body Weight

ArticleYear
The first observation of seasonal affective disorder symptoms in Rhesus macaque.
    Behavioural brain research, 2015, Oct-01, Volume: 292

    Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Clomipramine; Depression; Disease Models, An

2015
Metabonomics approach to assessing the modulatory effects of St John's wort, ginsenosides, and clomipramine in experimental depression.
    Journal of proteome research, 2012, Dec-07, Volume: 11, Issue:12

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Behavior, Animal; Body

2012
Differences in behavior and monoamine laterality following neonatal clomipramine treatment.
    Developmental psychobiology, 2002, Volume: 41, Issue:1

    Topics: Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Anxiety; Behavior

2002
Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume.
    Molecular psychiatry, 2002, Volume: 7, Issue:9

    Topics: Animals; Antidepressive Agents, Tricyclic; Body Weight; Brain Chemistry; Cell Division; Chronic Dise

2002
Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:1

    Topics: Animals; Animals, Newborn; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antigens, Nuclea

2006
Effect of chronic treatment with clomipramine on food intake, macronutrient selection and body weight gain in rats.
    Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:8

    Topics: Animals; Body Weight; Clomipramine; Diet; Dietary Carbohydrates; Eating; Food Preferences; Male; Pho

2007
Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol.
    Psychopharmacology, 1980, Volume: 68, Issue:3

    Topics: Animals; Biogenic Amines; Body Weight; Clomipramine; Dronabinol; Eating; Fluoxetine; Humans; Imipram

1980
Prenatal treatment with clomipramine has an anxiolytic profile in the adolescent rat.
    Physiology & behavior, 1983, Volume: 31, Issue:1

    Topics: Age Factors; Aggression; Animals; Anxiety; Behavior, Animal; Body Weight; Clomipramine; Environment;

1983
Suppression of active sleep by chronic treatment with chlorimipramine during early postnatal development: effects upon adult sleep and behavior in the rat.
    Brain research, 1981, Jan-05, Volume: 204, Issue:1

    Topics: Aggression; Aging; Animals; Animals, Newborn; Avoidance Learning; Behavior, Animal; Body Weight; Bra

1981
Does rapid-eye-movement sleep play a role in brain development?
    Progress in brain research, 1980, Volume: 53

    Topics: Animals; Behavior, Animal; Body Weight; Brain; Clomipramine; Female; Male; Organ Size; Rats; Sleep D

1980
Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. 1. On the sleepwaking cycles.
    Brain research, 1979, Jan-19, Volume: 160, Issue:3

    Topics: Age Factors; Animals; Animals, Newborn; Behavior, Animal; Body Weight; Brain; Cats; Clomipramine; Do

1979
Effects of chronic imipramine and clomipramine oral administration on maternal behavior and litter development.
    Psychopharmacology, 1978, Jan-31, Volume: 56, Issue:1

    Topics: Animals; Body Weight; Clomipramine; Dibenzazepines; Female; Growth; Imipramine; Maternal Behavior; M

1978
Clomipramine plasma level and clinical response.
    Postgraduate medical journal, 1977, Volume: 53 Suppl 4

    Topics: Administration, Oral; Adult; Aged; Body Weight; Clomipramine; Depression; Dibenzazepines; Female; Hu

1977
The effect of long-term administration of toxic doses of clomipramine on plasma prolactin, luteinizing hormone, follicle stimulating hormone and testosterone in the male rat.
    Postgraduate medical journal, 1977, Volume: 53 Suppl 4

    Topics: Animals; Body Weight; Clomipramine; Dibenzazepines; Follicle Stimulating Hormone; Luteinizing Hormon

1977
An investigation into the short-term effects of clomipramine (Anafranil) administered in low doses, on weight.
    The Journal of international medical research, 1977, Volume: 5, Issue:1 Suppl

    Topics: Body Weight; Clomipramine; Dibenzazepines; Female; Humans; Male

1977
Letter: A possible new treatment of weight loss in affective disorders and anorexia nervosa.
    The British journal of psychiatry : the journal of mental science, 1976, Volume: 128

    Topics: Adenosine Triphosphate; Affective Symptoms; Anorexia Nervosa; Body Weight; Clomipramine; Diazoxide;

1976
Caffeine enhances the speed of the recovery of the hypothalamo-pituitary-adrenocortical axis after chronic prednisolone administration in the rat.
    Neuroendocrinology, 1991, Volume: 54, Issue:5

    Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Animals; Body Weight; Caffeine; Clomipramine; Corticost

1991
Previous chronic chlorimipramine treatment did not modify some physiological responses to acute and chronic stress in rats.
    Psychopharmacology, 1988, Volume: 94, Issue:2

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Body Weight; Clomipramine; Corticosterone; Eat

1988
Clomipramine and 'drive' in people with anorexia nervosa: an in-patient study.
    The British journal of psychiatry : the journal of mental science, 1987, Volume: 150

    Topics: Adolescent; Adult; Anorexia Nervosa; Behavior; Body Weight; Clomipramine; Drive; Energy Intake; Fema

1987